Priority Date: 05.12.11 (EP 20110191922)

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

  • Application ID: EP12809640
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Technology Company

Specialization

This patent has the IPC class G01 (MEASURING; TESTING) is specialized in G01. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 05.12.2011 - Priority Date (EP 20110191922)
  • 13.06.2013 - Publication A1 (WO2013083499)
  • 15.10.2014 - Publication A1 (EP2788769)

IPC Classification